Melatonin-insulin interactions in type 1 diabetic rats
E Peschke, I Stumpf, K Hofmann, S Streck, E Albrecht, S Wolgast, D Wedekind, E Mühlbauer · Klinische Neurophysiologie · 2010 · Heft 03
Bibliografische Angaben
Zusammenfassung
Introduction: Melatonin receptors (MT1 and MT2) in pancreatic β-cells and both the adenylyl-cyclase-cAMP and guanylyl-cyclase-cGMP pathways are prerequisites for the well-known suppression of insulin secretion by melatonin. We found reduced melatonin plasma levels in type 2 diabetic patients as well as in type 2 diabetic Goto Kakizaki (GK) rats, a model of non-insulin-dependent diabetes mellitus (NIDDM). Previous studies have investigated the differences in glucose, insulin and melatonin levels in type 2 diabetic rats and humans. Moreover, expression of pineal insulin receptor (InsR)- and arylalkylamine-N-acetyl…